Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma
Clinical trial NCT00006100 · UNKNOWN
Trial details
- NCT number
- NCT00006100
- Sponsor
- Milton S. Hershey Medical Center
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2000-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.